RAP80/UIMC1 as cancer-associated antigen: Alternative splice variants and their immunogenicity

Cancer Letters

Volumn 255, Issue 2, 2007, Pages 255-262

  Shebzukhov, Yuriy V ^a   Koroleva, Ekaterina P ^b   Khlgatian, Svetlana V ^a   Belousov, Pavel V ^b   Sazykin, Alexey Y ^a   Kadachigova, Tatiana S ^a   Pomerantseva, Ekaterina A ^a   Lagarkova, Maria A ^a   Nedospasov, Sergei A ^a,b   Kuprash, Dmitry V ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Colon cancer; SEREX; Transcription

Indexed keywords

ISOPROTEIN; PROTEIN RAP80; PROTEIN UIMC1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; COLON TUMOR; CONTROLLED STUDY; EXON; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RNA SPLICING; TESTIS;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CARRIER PROTEINS; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS; NUCLEAR PROTEINS; TESTIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548029998     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.04.013     Document Type: Article

References (24)

1. Boon T., and Old L.J. Cancer tumor antigens. Curr. Opin. Immunol. 9 (1997) 681-683
2. Sahin U., Tureci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92 (1995) 11810-11813
3. Old L.J., and Chen Y.T. New paths in human cancer serology. J. Exp. Med. 187 (1998) 1163-1167
4. Tureci O., Sahin U., Zwick C., Neumann F., and Pfreundschuh M. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma 18 (1999) 23-28
5. Coronella-Wood J.A., and Hersh E.M. Naturally occurring B-cell responses to breast cancer. Cancer Immunol. Immunother. 52 (2003) 715-738
6. Preiss S., Kammertoens T., Lampert C., Willimsky G., and Blankenstein T. Tumor-induced antibodies resemble the response to tissue damage. Int. J. Cancer 115 (2005) 456-462
7. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den E.B., et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254 (1991) 1643-1647
8. Chen Y.T., Scanlan M.J., Sahin U., Tureci O., Gure A.O., Tsang S., et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94 (1997) 1914-1918
9. Jager E., Chen Y.T., Drijfhout J.W., Karbach J., Ringhoffer M., Jager D., et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187 (1998) 265-270
10. Stockert E., Jager E., Chen Y.T., Scanlan M.J., Gout I., Karbach J., et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187 (1998) 1349-1354
11. Scanlan M.J., Simpson A.J., and Old L.J. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4 1 (2004) 1
12. Lagarkova M.A., Koroleva E.P., Kuprash D.V., Boitchenko V.E., Kashkarova U.A., Nedospasov S.A., et al. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA). Immunol. Lett. 85 (2003) 71-74
13. Scanlan M.J., Chen Y.T., Williamson B., Gure A.O., Stockert E., Gordan J.D., et al. Characterization of human colon cancer antigens recognized by autologous antibodies. Int. J. Cancer 76 (1998) 652-658
14. Shebzukhov Y.V., Koroleva E.P., Khlgatian S.V., Lagarkova M.A., Meshcheryakov A.A., Lichinitser M.R., et al. Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy. Immunol. Lett. 100 (2005) 88-93
15. Yan Z., Kim Y.S., and Jetten A.M. RAP80, a novel nuclear protein that interacts with the retinoid-related testis-associated receptor. J. Biol. Chem. 277 (2002) 32379-32388
16. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99 (2002) 16899-16903
17. Kim Y.S., Nakanishi G., Oudes A.J., Kim K.H., Wang H., Kilpatrick D.L., et al. Tsp57: a novel gene induced during a specific stage of spermatogenesis. Biol. Reprod. 70 (2004) 106-113
18. Yan J., Kim Y.S., Yang X.P., Albers M., Koegl M., and Jetten A.M. Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor alpha. Nucleic Acids Res. 35 (2007) 1673-1686
19. Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA 101 (2004) 12130-12135
20. Scanlan M.J., Welt S., Gordon C.M., Chen Y.T., Gure A.O., Stockert E., et al. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res. 62 (2002) 4041-4047
21. Heubeck B., Wendler O., Bumm K., Schafer R., Muller-Vogt U., Hausler M., et al. Tumor-associated antigenic pattern in squamous cell carcinomas of the head and neck - analysed by SEREX. Eur. J. Cancer (2006) 10.1016/j.ejca.2005.09.036
22. Wang B., Matsuoka S., Ballif B.A., Zhang D., Smogorzewska A., Gygi S.P., and Elledge S.J. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316 (2007) 1194-1198
23. Sobhian B., Shao G., Lilli D.R., Culhane A.C., Moreau L.A., Xia B., Livingston D.M., and Greenberg R.A. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316 (2007) 1198-1202
24. Kim H., Chen J., and Yu X. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316 (2007) 1202-1205